Health

Clarivate Identifies Six Breakthrough MedTech Trends in 2024 Set to Unlock New Industry Opportunities

New report highlights challenges and opportunities in resilient MedTech industry LONDON, July 2, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the release of theMedTech Trends to Watch 2024 report, the second installment...

2024-07-02 15:00 1922

PharmAbcine's Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration Advances to Both Single-dose of 4mg and Multiple-dose of 3mg

* Safety Review Committee (SRC) approves single 3mg dose for the third cohort in Phase 1 trial of PMC-403 DAEJEON, South Korea, July 2, 2024 /PRNewswire/ -- PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ:208340), a clinical-stage public company developing next generation therapeutic...

2024-07-02 11:02 2146

Noul Co., Ltd. Releases 2023-2024 Sustainability Report

* CEO David Lim: "Committed to achieving genuine ESG practices and outstanding business performance simultaneously" * First KOSDAQ-listed medical AI company to publish a sustainability report * Reflecting a commitment to AI technology for social impact and social responsibility YONGIN, South...

2024-07-02 10:52 2517

HiRO acquires CRO DeltaMed Solutions, continues to expand cross-border operations in the US

WILMINGTON, Del., July 2, 2024 /PRNewswire/ -- Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful acquisition of DeltaMed Solutions, an emerging CRO with a robust foothold in the US. The acquis...

2024-07-02 10:00 3401

Cicada Innovations calls for systems approach to 'turbocharge' Future Made in Australia act, announces Tech23 cohort

SYDNEY, July 2, 2024 /PRNewswire/ -- Australia's flagship deep tech incubator Cicada Innovations is urging the tech ecosystem to lead in turbocharging the Future Made inAustralia act by shifting from a "silos" to a "systems" approach that aligns national vi...

2024-07-02 08:06 2938

Altos Biologics Files for Approval of Aflibercept Biosimilar

DAEJEON, South Korea, July 1, 2024 /PRNewswire/ -- Alteogen Inc. (KOSDAQ: 196170) announced on July 1st that its subsidiary, Altos Biologics Inc. has submitted Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for an aflibercept bi...

2024-07-02 08:00 2788

Innovent Announces Oral Presentation at the ESMO Gastrointestinal Cancers Congress 2024 on Latest Clinical Data of Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

SAN FRANCISCO and SUZHOU, China, July 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...

2024-07-02 08:00 3544

Bridgewest Perth Pharma gains strategic edge with noted Australian Executive John Van Der Wielen on Board

PERTH, Australia, July 2, 2024 /PRNewswire/ -- Bridgewest Perth Pharma, global pharmaceutical holding company withNovaCina CDMO division and LumaCina  pharmaceutical supply division, announces the addition of renown Australian executiveJohn Van Der Wielen to Board of Directors. Van Der Wielen will...

2024-07-02 07:00 2085

Lions Celebrate a Successful Year of Service at the 106th Lions International Convention

OAK BROOK, Ill., July 2, 2024 /PRNewswire/ -- Lions International celebrated several milestones during the 106th Lions International Convention inMelbourne, Australia. Nearly 10,000 Lions attended this pinnacle event to reconnect with Lions from around the world, discover innovative ways to grow ...

2024-07-02 07:00 1759

Datasea Enters into New Sales Agreements for its 5G AI Communications and High Tech Acoustic Segments Expecting $62 Million in Sales

The Three Agreements Support Continued Fiscal Year 2025 Revenue Growth for its Core AI-Based Businesses BEIJING, July 1, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada corporation engaged in innovative businesses in high-tech intelligent acoustics and 5G-A...

2024-07-01 21:30 4217

JCI Publishes 8th Edition of International Accreditation Standards for Hospitals and Academic Medical Centers

8th edition strengthens existing standards to advance patient safety and quality improvement OAKBROOK TERRACE, Ill., July 1, 2024 /PRNewswire/ -- Joint Commission International (JCI) has released the 8th edition of its Accreditation Standards for Hospitals and Academic Medical Centers. These evi...

2024-07-01 21:00 2030

HistoIndex Charts New Course in Liver Disease Innovation: Announces Pivotal Changes to Scientific Advisory Board

* Company to appoint Prof. Arun J. Sanyal as the new Chairman of HistoIndex's Scientific Advisory Board, bringing unparalleled expertise to guide future innovations. * Prof. Vlad Ratziu joins the Scientific Advisory Board to strengthen the Company's global scientific leadership in liver disea...

2024-07-01 20:00 2554

Ping An Co-CEO Michael Guo at "Summer Davos": Low Public Awareness of Financial Planning for Senior Care in China is Opportunity for Financial Services Industry

HONG KONG and SHANGHAI, July 1, 2024 /PRNewswire/ -- China's growing senior population is bringing tremendous business opportunities to the financial services industry, says Michael Guo, Co-CEO of Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An", the "Company" or the "Group", ...

2024-07-01 19:19 4639

Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million

YANGZHOU, China, July 1, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, announced today that its board o...

2024-07-01 18:00 1902

"Twenty Years of Collaboration Leading to New Success" - The 20th Anniversary Press Conference of Medtec China Successfully Held in Shanghai

SHANGHAI, July 1, 2024 /PRNewswire/ -- On the morning of June 26, 2024, the  20th Anniversary Press Conference of Medtec China was successfully held at the Grand Kempinski Hotel Shanghai. Mr.Jack Wei, General Manager of Informa Markets Beijing announced Medtec's new development strategy to establ...

2024-07-01 16:08 2018

IFPA Celebrates Success of the 7th IFPA Conference 2024

STOCKHOLM, July 1, 2024 /PRNewswire/ -- IFPA (The International Federation of Psoriasis Associations) concluded its highly anticipated 7th IFPA Conference on World Psoriasis and Psoriatic Arthritis, held fromJune 27 to 29, 2024, in Stockholm, Sweden. Established in 2006, the conference has become...

2024-07-01 16:00 1735

IASO Bio Presented Clinical Data and Single-cell Analysis of Equecabtagene Autoleucel for the Treatment of Central Nervous System Autoimmunity in Oral Presentation at EAN Congress 2024

SHANGHAI, NANJING, CHINA, and SAN JOSE, Calif., July 1, 2024 /PRNewswire/ -- IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, presented the clinical data and single-cell an...

2024-07-01 15:43 1481

National Cancer Society Malaysia and Gene Solutions Forge Partnership to Expand Multi-Cancer Early Detection Awareness and Access

KUALA LUMPUR, Malaysia, July 1, 2024 /PRNewswire/ -- National Cancer Society Malaysia (NCSM) and Gene Solutions are pleased to announce the signing of a Memorandum of Understanding (MOU) to collaborate on expanding awareness and enabling access to multi-cancer early detection (MCED) testing for t...

2024-07-01 12:55 14165

Egg White Rice - an Innovative Food for the Health-Conscious

BANGKOK, July 1, 2024 /PRNewswire/ -- Chula   Faculty of Allied Health Sciences has launched a ready-to-eat flourless rice innovation made from egg whites, branded as"eggyday ".  This product is low in...

2024-07-01 11:56 2164

SCG Cell Therapy Announces FDA IND Clearance of SCG142, a next-generation HPV-specific TCR T cell therapy for patients with HPV-associated solid tumors

SINGAPORE, July 1, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) appl...

2024-07-01 10:56 1979
1 ... 62636465666768 ... 858